News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,716 Results
Type
Article (1923)
Company Profile (3)
Press Release (69790)
Section
Business (21470)
Career Advice (9)
Deals (4552)
Drug Development (8160)
FDA (1804)
Job Trends (800)
News (37031)
Policy (3562)
Tag
Academia (94)
Accelerated approval (2)
Allergies (11)
Alliances (8172)
ALS (10)
Alzheimer's disease (153)
Antibody-drug conjugate (ADC) (48)
Approvals (1891)
Artificial intelligence (24)
Autoimmune disease (9)
Automation (1)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (56)
Biotechnology (5)
Bladder cancer (24)
Brain cancer (5)
Breast cancer (45)
Cancer (441)
Cardiovascular disease (15)
Career advice (9)
CAR-T (12)
Cell therapy (45)
Cervical cancer (3)
Clinical research (7366)
Collaboration (202)
Compensation (17)
Complete response letters (5)
COVID-19 (194)
C-suite (51)
Cystic fibrosis (6)
Data (531)
Depression (10)
Diabetes (28)
Diagnostics (618)
Digital health (4)
Drug discovery (29)
Duchenne muscular dystrophy (25)
Earnings (7909)
Events (7296)
Executive appointments (59)
FDA (2137)
Fibrodysplasia Ossificans Progressiva (1)
Funding (105)
Gene editing (4)
Generative AI (2)
Gene therapy (27)
GLP-1 (63)
Government (234)
Grass and pollen (1)
Guidances (38)
Healthcare (1079)
HIV (1)
Huntington's disease (2)
IgA nephropathy (18)
Immunology and inflammation (5)
Immuno-oncology (2)
Indications (7)
Infectious disease (207)
Inflammatory bowel disease (22)
Inflation Reduction Act (1)
Influenza (10)
Intellectual property (27)
IPO (1638)
Job creations (241)
Job search strategy (9)
Layoffs (6)
Legal (953)
Liver cancer (18)
Lung cancer (84)
Lymphoma (34)
Manufacturing (70)
MASH (11)
Medical device (1148)
Medtech (1151)
Mergers & acquisitions (3060)
Metabolic disorders (64)
Multiple sclerosis (12)
NASH (1)
Neurodegenerative disease (23)
Neuropsychiatric disorders (5)
Neuroscience (247)
NextGen: Class of 2025 (219)
Non-profit (62)
Obesity (21)
Opinion (2)
Ovarian cancer (21)
Pain (7)
Pancreatic cancer (12)
Parkinson's disease (27)
Partnered (2)
Patents (46)
Patient recruitment (36)
Peanut (1)
People (5066)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase I (1985)
Phase II (3106)
Phase III (2789)
Pipeline (400)
Policy (1)
Postmarket research (241)
Preclinical (689)
Press Release (2)
Prostate cancer (17)
Radiopharmaceuticals (22)
Rare diseases (50)
Real estate (605)
Regulatory (2800)
Reports (6)
Research institute (97)
RNA editing (1)
RSV (2)
Schizophrenia (14)
Series A (21)
Series B (17)
Service/supplier (1)
Sickle cell disease (5)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (12)
Vaccines (37)
Venture capital (2)
Weight loss (4)
Women's health (2)
Date
Today (6)
Last 7 days (48)
Last 30 days (242)
Last 365 days (2709)
2025 (2607)
2024 (3253)
2023 (3814)
2022 (7013)
2021 (6372)
2020 (5872)
2019 (3867)
2018 (3013)
2017 (3562)
2016 (3176)
2015 (4030)
2014 (3020)
2013 (2604)
2012 (2775)
2011 (2903)
2010 (2663)
Location
Africa (87)
Alabama (3)
Arizona (10)
Asia (21866)
Australia (2460)
California (595)
Canada (341)
China (326)
Colorado (4)
Connecticut (21)
Delaware (6)
Europe (12929)
Florida (54)
Georgia (12)
Illinois (24)
India (31)
Indiana (12)
Japan (204)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (103)
Massachusetts (442)
Michigan (5)
Minnesota (33)
Missouri (3)
Nebraska (1)
Nevada (6)
New Hampshire (1)
New Jersey (348)
New York (205)
North Carolina (86)
Northern California (249)
Ohio (3)
Oregon (1)
Pennsylvania (101)
Rhode Island (1)
South America (107)
Southern California (278)
Tennessee (1)
Texas (50)
United States (2206)
Utah (20)
Virginia (41)
Washington D.C. (3)
Washington State (39)
Wisconsin (7)
71,716 Results for "evogene ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Faron Pharmaceuticals Ltd: Appointment of CFO
December 1, 2025
·
3 min read
Press Releases
Faron Pharmaceuticals Ltd: Holding(s) in Company
December 5, 2025
·
3 min read
Business
Evogene Schedules First Quarter 2024 Financial Results Release
Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development, announced that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024.
May 9, 2024
·
2 min read
Business
Evogene Reports First Quarter 2024 Financial Results
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter period ended March 31, 2024.
May 23, 2024
·
18 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
·
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
·
4 min read
Press Releases
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
December 8, 2025
·
10 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Upcoming December 2025 Investor Conference
December 3, 2025
·
1 min read
Business
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Evogene Ltd. today announced its financial results for the fourth quarter and full-year period ending December 31, 2023.
March 7, 2024
·
19 min read
Press Releases
Kestra Medical Technologies, Ltd. Announces Primary Public Offering of Common Shares
December 2, 2025
·
4 min read
1 of 7,172
Next
